These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 20099999)

  • 1. Patenting bioactive molecules from biodiversity: the Brazilian experience.
    Nogueira RC; de Cerqueira HF; Soares MB
    Expert Opin Ther Pat; 2010 Feb; 20(2):145-57. PubMed ID: 20099999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UIC ICBG (University of Illinois at Chicago International Cooperative Biodiversity Group) Memorandum of Agreement: a model of benefit-sharing arrangement in natural products drug discovery and development.
    Soejarto DD; Gyllenhaal C; Fong HH; Xuan LT; Hiep NT; Hung NV; Bich TQ; Southavong B; Sydara K; Pezzuto JM
    J Nat Prod; 2004 Feb; 67(2):294-9. PubMed ID: 14987071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.
    Soejarto DD; Zhang HJ; Fong HH; Tan GT; Ma CY; Gyllenhaal C; Riley MC; Kadushin MR; Franzblau SG; Bich TQ; Cuong NM; Hiep NT; Loc PK; Xuan le T; Hai NV; Hung NV; Chien NQ; Binh le T; Vu BM; Ly HM; Southavong B; Sydara K; Bouamanivong S; Pezzuto JM; Rose WC; Dietzman GR; Miller BE; Thuy TV
    J Nat Prod; 2006 Mar; 69(3):473-81. PubMed ID: 16562860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New rules for natural products research.
    Gollin MA
    Nat Biotechnol; 1999 Sep; 17(9):921-2. PubMed ID: 10471938
    [No Abstract]   [Full Text] [Related]  

  • 5. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If biological diversity has a price, who sets it and who should benefit?
    Gershon D
    Nature; 1992 Oct; 359(6396):565. PubMed ID: 1406979
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicinal plant genetic resources and international cooperation: the Brazilian perspective.
    Elisabetsky E; Costa-Campos L
    J Ethnopharmacol; 1996 Apr; 51(1-3):111-9; discussion 119-20. PubMed ID: 9213607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserving biodiversity using patent law.
    Székely T; Gaillard A
    Nat Biotechnol; 2007 Oct; 25(10):1087-8. PubMed ID: 17921985
    [No Abstract]   [Full Text] [Related]  

  • 11. Patents of drugs extracted from Brazilian medicinal plants.
    Balbani AP; Silva DH; Montovani JC
    Expert Opin Ther Pat; 2009 Apr; 19(4):461-73. PubMed ID: 19441926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convention on Biological Diversity. U.N. biodiversity summit yields welcome and unexpected progress.
    Normile D
    Science; 2010 Nov; 330(6005):742-3. PubMed ID: 21051603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural resources: bioprospects less than golden.
    Dalton R
    Nature; 2004 Jun; 429(6992):598-600. PubMed ID: 15190324
    [No Abstract]   [Full Text] [Related]  

  • 15. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 16. Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property.
    Hamilton C
    Dev World Bioeth; 2006 Dec; 6(3):158-73. PubMed ID: 17038007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia.
    Calle R
    J Ethnopharmacol; 1996 Apr; 51(1-3):127-42; discussion 142-6. PubMed ID: 9213609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neotropics and natural ingredients for pharmaceuticals: why isn't South American biodiversity on the crest of the wave?
    Desmarchelier C
    Phytother Res; 2010 Jun; 24(6):791-9. PubMed ID: 20127883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development.
    Oliva MJ
    Planta Med; 2011 Jul; 77(11):1221-7. PubMed ID: 21674434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.